期刊文献+
共找到2篇文章
< 1 >
每页显示 20 50 100
Are we close to using Alzheimer blood biomarkers in clinical practice? 被引量:1
1
作者 Bruno P.Imbimbo simone lista +1 位作者 Camillo Imbimbo Robert Nisticò 《Neural Regeneration Research》 SCIE CAS CSCD 2024年第12期2583-2585,共3页
Alzheimer's disease(AD) is a progressive neurodegenerative disease histologically characterized by the presence of extraneuronal plaques,mainly formed by the 42-aminoacid isoform of amyloid-(Aβ_(1-42)),and by int... Alzheimer's disease(AD) is a progressive neurodegenerative disease histologically characterized by the presence of extraneuronal plaques,mainly formed by the 42-aminoacid isoform of amyloid-(Aβ_(1-42)),and by intraneuronal neurofibrillary to ngles,mainly formed by the tau protein and its hyperphosphorylated isoforms(p-tau).AD is the most common cause of dementia,with an estimated lifetime risk of about 1 in 10 for men and 1 in 5 for women. 展开更多
关键词 ALZHEIMER TAU
暂未订购
Biomarker-guided classificatio scheme of neurodegenerative diseases
2
作者 Filippo Baldacci simone lista +3 位作者 Francesco Garaci Ubaldo Bonuccelli Nicola Toschi Harald Hampel 《Journal of Sport and Health Science》 SCIE 2016年第4期383-387,共5页
1.The complex spectrum of neurodegenerative diseases Epidemiologic data indicate that neurodegenerative diseases(NDDs)show high prevalence with a trend of a progressively growing incidence,especially in aging societie... 1.The complex spectrum of neurodegenerative diseases Epidemiologic data indicate that neurodegenerative diseases(NDDs)show high prevalence with a trend of a progressively growing incidence,especially in aging societies.This presents an increasing social and economic burden. 展开更多
暂未订购
上一页 1 下一页 到第
使用帮助 返回顶部